| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-15 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
5e-14 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-14 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-14 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-13 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-13 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-12 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
5e-12 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-12 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-12 |